Tourette syndrome is a real, well-documented neurological condition with measurable differences in brain structure and function. It affects roughly 1 in 162 children, and brain imaging studies show distinct patterns of activity in people with the condition that are not present in those without it. The question of whether Tourette’s is “real” comes up partly because of how it’s portrayed in media, but decades of genetics research, brain scans, and clinical evidence leave no scientific doubt.
What Happens in the Brain
Tourette syndrome involves a malfunction in the circuits connecting several brain regions that control movement. In a typical brain, a structure called the basal ganglia acts like a gatekeeper: it helps select which movements to allow and which to suppress. It does this through a double-inhibition mechanism, essentially putting the brakes on unwanted movements while letting intentional ones through.
In people with Tourette’s, excess dopamine in a part of the basal ganglia called the striatum disrupts this gatekeeper system. The result is that certain motor patterns get “released” when they shouldn’t be, producing tics. More recent research shows the cerebellum (which fine-tunes movement) is also involved, working in concert with the basal ganglia and the outer layer of the brain to generate tics. This isn’t a single broken switch. It’s a miscommunication across an entire loop of brain regions.
Functional MRI studies have directly observed these differences. During tic suppression, people with Tourette’s show decreased activity in parts of the basal ganglia (the putamen and globus pallidus) and increased activity in the caudate nucleus. The severity of someone’s tics correlates inversely with how much signal change appears in the basal ganglia and thalamus, meaning the worse the tics, the less these regions are able to compensate. These are objective, measurable findings visible on a brain scan.
The Genetic Evidence
Tourette syndrome is one of the most heritable neuropsychiatric conditions that begins in childhood. Studies of identical twins show concordance rates between 50% and 77% for Tourette’s specifically, and up to 94% when including other tic disorders. For non-identical twins, concordance drops to 10% to 23%. That gap between identical and non-identical twins is strong evidence that genes play a major role.
Researchers have identified several specific genetic mutations linked to the condition. One notable finding involved a mutation in a gene responsible for producing histamine, an important chemical messenger in the brain. Other genetic disruptions have been found in genes also implicated in autism spectrum disorder and schizophrenia, suggesting some shared biological roots across neurodevelopmental conditions. No single “Tourette’s gene” has been found, which is typical of complex brain conditions. Multiple genes each contribute a small amount of risk.
How It’s Formally Diagnosed
Tourette syndrome has clear diagnostic criteria recognized by both the American Psychiatric Association and the World Health Organization. To meet the threshold, a person must have at least two motor tics and at least one vocal tic, persisting for a year or more. The DSM-5 classifies it as a neurodevelopmental disorder, placing it alongside ADHD and autism spectrum disorder.
There is no blood test or single scan that diagnoses Tourette’s. Diagnosis is based on clinical observation and history, which is true of many neurological and psychiatric conditions. The absence of a lab test does not mean the condition is subjective or invented. Migraine, epilepsy in many of its forms, and concussions are all diagnosed primarily through clinical assessment.
What Tics Actually Feel Like
One of the strongest pieces of evidence that Tourette’s is a genuine neurological phenomenon is what patients consistently describe feeling before a tic occurs. About 84% of people with Tourette’s report a “premonitory urge,” a mounting inner tension or uncomfortable sensation in a specific body area that builds until the tic is performed. Expressing the tic provides brief relief, but the sensation returns.
These urges are often described as focal, limited to the exact body part where the tic will occur. Some people experience a more generalized sense of inner tension. Others describe a “just-right” phenomenon, a feeling that something doesn’t look, feel, or sound correct until the tic is completed. This “just-right” sensation is most commonly triggered by visual or tactile input. These subjective experiences are remarkably consistent across patients worldwide, which points to a shared underlying biology rather than a behavioral choice.
Why People Question It
Much of the skepticism around Tourette’s comes from media portrayals that focus almost exclusively on coprolalia, the involuntary shouting of obscene words. In reality, coprolalia affects only about 1 in 10 people with Tourette’s. The vast majority experience simpler tics: eye blinking, head jerking, throat clearing, sniffing, or shoulder shrugging. Because these common tics can look like habits or nervous behaviors, it’s easy for an outside observer to assume the person could just stop if they tried hard enough.
That assumption is wrong. Brain imaging shows that suppressing tics requires significant neurological effort, activating additional brain regions involved in attention and self-control. People with Tourette’s can sometimes delay tics temporarily, much like you might hold back a sneeze, but the underlying neurological impulse doesn’t go away. The tic eventually happens, often with greater intensity after a period of suppression.
Social media has added another layer of confusion. Some high-profile cases of people allegedly faking tics for attention have made the public more suspicious of the diagnosis in general. Clinicians are aware of this phenomenon, but it does not change the reality for the estimated 174,000 children in the United States who have received a Tourette’s diagnosis, or the many more who remain undiagnosed.
How Tourette’s Is Managed
Because Tourette syndrome involves excess dopamine activity in specific brain circuits, treatments that reduce dopamine signaling can help control tics. Not everyone with Tourette’s needs medication. For many children, tics peak in severity around ages 10 to 12 and gradually improve through adolescence.
Behavioral therapy is often the first approach. A technique called habit reversal training teaches people to recognize the premonitory urge and perform a competing response, a voluntary movement that is incompatible with the tic. This doesn’t cure the condition, but it can reduce tic frequency and severity significantly. For people whose tics are disruptive enough to interfere with daily life, medication that modulates dopamine or other neurotransmitters is an option, though side effects vary and finding the right fit can take time.
The fact that both behavioral and pharmacological interventions work through the same neurological pathways described in brain imaging studies reinforces that Tourette’s is a condition with a clear biological basis, not a behavioral quirk or a bid for attention.